Literature DB >> 28911381

The effects of methadone maintenance treatment on heroin addicts with response inhibition function impairments: Evidence from event-related potentials.

Ling Yang1, Qiongying Xu2, Shifeng Li3, Xin Zhao4, Li Ma1, Youfen Zheng1, Juanjuan Zhang1, Yi Li1.   

Abstract

Response inhibition has been a core issue in addictive behavior. Many previous studies have found that response inhibition abilities are damaged in those with drug dependence. However, whether heroin addicts who are treated with methadone maintenance have an abnormal response inhibition ability is not clear. In order to investigate the response inhibition functions in heroin addicts who were treated with methadone maintenance, electroencephalography (EEG) was used to examine 14 heroin addicts treated with methadone maintenance (HDM), 17 heroin addicts (HD), and 18 healthy controls (HC) in an equiprobability Go∖NoGo task. The reaction times (RTs) for the Go stimuli in the HD group were slower than those in the HDM and HC groups. Event-related potential (ERP) measurements showed that NoGo stimuli elicited larger N2 amplitudes than Go stimuli in the HDM and HC groups. However, for the HD group, the N2 amplitudes were similar for the two conditions. In addition, the HDM and HD groups were associated with longer P3 latencies. Our results demonstrated that methadone maintenance treatment might ease the deficits in response inhibition that result from long-term drug abuse. However, compared to normal people, HDM patients have serious problems evaluating and inhibiting inappropriate behaviors.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  N2; P3; event-related potential (ERP); heroin addiction; methadone maintenance treatment; response inhibition

Year:  2014        PMID: 28911381      PMCID: PMC9351767          DOI: 10.1016/j.jfda.2014.06.002

Source DB:  PubMed          Journal:  J Food Drug Anal            Impact factor:   6.157


  20 in total

1.  The auditory-evoked N2 and P3 components in the stop-signal task: indices of inhibition, response-conflict or error-detection?

Authors:  Aneta Dimoska; Stuart J Johnstone; Robert J Barry
Journal:  Brain Cogn       Date:  2006-06-30       Impact factor: 2.310

Review 2.  Neuropsychology and neuropharmacology of P3a and P3b.

Authors:  John Polich; José R Criado
Journal:  Int J Psychophysiol       Date:  2006-02-28       Impact factor: 2.997

3.  Imaging response inhibition in a stop-signal task: neural correlates independent of signal monitoring and post-response processing.

Authors:  Chiang-shan Ray Li; Cong Huang; R Todd Constable; Rajita Sinha
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

4.  Event-related potentials in a Go/Nogo task of abnormal response inhibition in heroin addicts.

Authors:  Bo Yang; SuYong Yang; Lun Zhao; LiuHua Yin; Xu Liu; ShaSha An
Journal:  Sci China C Life Sci       Date:  2009-08-29

5.  Three-dimensional tomography of event-related potentials during response inhibition: evidence for phasic frontal lobe activation.

Authors:  W K Strik; A J Fallgatter; D Brandeis; R D Pascual-Marqui
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1998-07

6.  [Opioid addiction: P300 assessment in treatment by methadone substitution].

Authors:  A Attou; C Figiel; M Timsit-Berthier
Journal:  Neurophysiol Clin       Date:  2001-06       Impact factor: 3.734

7.  Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.

Authors:  Antonio Verdejo; Inmaculada Toribio; Carmen Orozco; Krista Lee Puente; Miguel Pérez-García
Journal:  Drug Alcohol Depend       Date:  2004-12-23       Impact factor: 4.492

8.  Blunted activation in right ventrolateral prefrontal cortex during motor response inhibition in schizophrenia.

Authors:  Arthur Kaladjian; Régine Jeanningros; Jean-Michel Azorin; Stephan Grimault; Jean-Luc Anton; Pascale Mazzola-Pomietto
Journal:  Schizophr Res       Date:  2007-09-12       Impact factor: 4.939

9.  Current status of drug use and HIV/AIDS prevention in drug users in China.

Authors:  Jianhua Li; Xinyue Li
Journal:  J Food Drug Anal       Date:  2013-12       Impact factor: 6.079

10.  Electrophysiological evidence for reduced inhibitory control in depressed patients in partial remission: a Go/Nogo study.

Authors:  Martin Ruchsow; Georg Groen; Markus Kiefer; Petra Beschoner; Leopold Hermle; Dietrich Ebert; Michael Falkenstein
Journal:  Int J Psychophysiol       Date:  2008-02-12       Impact factor: 2.997

View more
  6 in total

1.  Reduction in N2 amplitude in response to deviant drug-related stimuli during a two-choice oddball task in long-term heroin abstainers.

Authors:  Bobo Su; Sha Wang; Alexander Sumich; Shaomei Li; Ling Yang; Yueyue Cai; Grace Y Wang
Journal:  Psychopharmacology (Berl)       Date:  2017-08-04       Impact factor: 4.530

2.  Cigarette-specific disgust aroused by smoking warning images strengthens smokers' inhibitory control under smoking-related background in Go/NoGo task.

Authors:  Xinwei Li; Weijian Li; Haide Chen; Ningmeng Cao; Boqiang Zhao
Journal:  Psychopharmacology (Berl)       Date:  2021-06-24       Impact factor: 4.530

3.  Acute Aerobic Exercise Ameliorates Cravings and Inhibitory Control in Heroin Addicts: Evidence From Event-Related Potentials and Frequency Bands.

Authors:  Dongshi Wang; Ting Zhu; Jiachen Chen; Yingzhi Lu; Chenglin Zhou; Yu-Kai Chang
Journal:  Front Psychol       Date:  2020-09-29

4.  Reduced response inhibition after exposure to drug-related cues in male heroin abstainers.

Authors:  Bobo Su; Shaomei Li; Ling Yang; Meihong Zheng
Journal:  Psychopharmacology (Berl)       Date:  2020-01-08       Impact factor: 4.530

Review 5.  Forging Neuroimaging Targets for Recovery in Opioid Use Disorder.

Authors:  Jennifer L Stewart; April C May; Robin L Aupperle; Jerzy Bodurka
Journal:  Front Psychiatry       Date:  2019-03-07       Impact factor: 4.157

Review 6.  Bouncing back: Brain rehabilitation amid opioid and stimulant epidemics.

Authors:  Jennifer L Stewart; April C May; Martin P Paulus
Journal:  Neuroimage Clin       Date:  2019-11-05       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.